234 related articles for article (PubMed ID: 22796671)
1. Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta.
Toba H; Kojima Y; Wang J; Noda K; Tian W; Kobara M; Nakata T
Eur J Pharmacol; 2012 Sep; 691(1-3):190-7. PubMed ID: 22796671
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta.
Toba H; Morishita M; Tojo C; Nakano A; Oshima Y; Kojima Y; Yoshida M; Nakashima K; Wang J; Kobara M; Nakata T
Eur J Pharmacol; 2011 Apr; 656(1-3):81-7. PubMed ID: 21296066
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis.
Toba H; Nakashima K; Oshima Y; Kojima Y; Tojo C; Nakano A; Wang J; Kobara M; Nakata T
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1139-46. PubMed ID: 20819095
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction, macrophage infiltration and NADPH oxidase-dependent superoxide production were attenuated by erythropoietin in streptozotocin-induced diabetic rat aorta.
Wang J; Toba H; Morita Y; Nakashima K; Noda K; Tian W; Kobara M; Nakata T
Pharmacology; 2013; 91(1-2):48-58. PubMed ID: 23154660
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat.
Toba H; Sawai N; Morishita M; Murata S; Yoshida M; Nakashima K; Morita Y; Kobara M; Nakata T
Eur J Pharmacol; 2009 Jun; 612(1-3):106-14. PubMed ID: 19356735
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
9. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
[TBL] [Abstract][Full Text] [Related]
10. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Harrison CB; Drummond GR; Sobey CG; Selemidis S
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats.
Kawczynska-Drozdz A; Olszanecki R; Jawien J; Brzozowski T; Pawlik WW; Korbut R; Guzik TJ
Am J Hypertens; 2006 Jul; 19(7):764-7. PubMed ID: 16814134
[TBL] [Abstract][Full Text] [Related]
12. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta.
Loomis ED; Sullivan JC; Osmond DA; Pollock DM; Pollock JS
J Pharmacol Exp Ther; 2005 Dec; 315(3):1058-64. PubMed ID: 16144972
[TBL] [Abstract][Full Text] [Related]
13. Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?
Zalba G; Beaumont FJ; San José G; Fortuño A; Fortuño MA; Díez J
Nephrol Dial Transplant; 2001; 16 Suppl 1():2-5. PubMed ID: 11369811
[TBL] [Abstract][Full Text] [Related]
14. Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin.
Meziri F; Binda D; Touati S; Pellegrin M; Berthelot A; Touyz RM; Laurant P
Eur J Appl Physiol; 2011 Aug; 111(8):1929-38. PubMed ID: 21249387
[TBL] [Abstract][Full Text] [Related]
15. Baicalein impairs vascular tone in normal rat aortas: role of superoxide anions.
Machha A; Achike FI; Mohd MA; Mustafa MR
Eur J Pharmacol; 2007 Jun; 565(1-3):144-50. PubMed ID: 17442302
[TBL] [Abstract][Full Text] [Related]
16. Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats.
Tsukahara H; Hiraoka M; Hori C; Hata I; Okada T; Gejyo F; Sudo M
Scand J Clin Lab Invest; 1997 Oct; 57(6):487-93. PubMed ID: 9350067
[TBL] [Abstract][Full Text] [Related]
17. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency.
Nakmareong S; Kukongviriyapan U; Pakdeechote P; Kukongviriyapan V; Kongyingyoes B; Donpunha W; Prachaney P; Phisalaphong C
Hypertens Res; 2012 Apr; 35(4):418-25. PubMed ID: 22072109
[TBL] [Abstract][Full Text] [Related]
19. Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats.
Moreau C; Larivière R; Kingma I; Grose JH; Lebel M
Clin Exp Hypertens; 2000; 22(7-8):663-74. PubMed ID: 11131043
[TBL] [Abstract][Full Text] [Related]
20. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.
Virdis A; Iglarz M; Neves MF; Amiri F; Touyz RM; Rozen R; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1352-7. PubMed ID: 12829522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
